RYR2 and catecholaminergic polymorphic ventricular tachycardia: However, it may serve useful for testing potential treatments and/or mechanistic investigations for some CPVT-linked RYR2 mutations including deletion of exon-3, G357S point mutation (49, 50) or RYR2 loss of function mutations that result in reduced RYR2 protein levels (51).